vs
Side-by-side financial comparison of Dollar Tree (DLTR) and GE HealthCare (GEHC). Click either name above to swap in a different company.
GE HealthCare is the larger business by last-quarter revenue ($5.7B vs $4.7B, roughly 1.2× Dollar Tree). GE HealthCare runs the higher net margin — 10.3% vs 5.2%, a 5.2% gap on every dollar of revenue. On growth, GE HealthCare posted the faster year-over-year revenue change (7.1% vs -37.2%). Over the past eight quarters, GE HealthCare's revenue compounded faster (10.7% CAGR vs -25.9%).
Dollar Tree, Inc., formerly known as Dollar Tree Stores, Inc., is an American multi-price-point chain of discount variety stores. Headquartered in Chesapeake, Virginia, it is a Fortune 500 company and operates 15,115 stores throughout the 48 contiguous U.S. states and Canada. Its stores are supported by a nationwide logistics network of 24 distribution centers.
GE Healthcare Technologies, Inc., stylized GE HealthCare, is an American health technology company based in Chicago, Illinois. It operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures...
DLTR vs GEHC — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $4.7B | $5.7B |
| Net Profit | $244.6M | $588.0M |
| Gross Margin | 35.8% | 39.7% |
| Operating Margin | 7.2% | 14.5% |
| Net Margin | 5.2% | 10.3% |
| Revenue YoY | -37.2% | 7.1% |
| Net Profit YoY | 4.8% | -18.4% |
| EPS (diluted) | $1.20 | $1.28 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $4.7B | $5.7B | ||
| Q3 25 | $4.6B | $5.1B | ||
| Q2 25 | $4.6B | $5.0B | ||
| Q1 25 | $5.0B | $4.8B | ||
| Q4 24 | $7.6B | $5.3B | ||
| Q3 24 | $7.4B | $4.9B | ||
| Q2 24 | $7.6B | $4.8B | ||
| Q1 24 | $8.6B | $4.7B |
| Q4 25 | $244.6M | $588.0M | ||
| Q3 25 | $188.4M | $446.0M | ||
| Q2 25 | $343.4M | $486.0M | ||
| Q1 25 | $-3.7B | $564.0M | ||
| Q4 24 | $233.3M | $721.0M | ||
| Q3 24 | $132.4M | $470.0M | ||
| Q2 24 | $300.1M | $428.0M | ||
| Q1 24 | $-1.7B | $374.0M |
| Q4 25 | 35.8% | 39.7% | ||
| Q3 25 | 34.4% | 38.7% | ||
| Q2 25 | 35.6% | 39.6% | ||
| Q1 25 | 37.6% | 42.1% | ||
| Q4 24 | 30.9% | 42.8% | ||
| Q3 24 | 30.0% | 41.7% | ||
| Q2 24 | 30.8% | 41.4% | ||
| Q1 24 | 32.1% | 40.9% |
| Q4 25 | 7.2% | 14.5% | ||
| Q3 25 | 5.1% | 12.7% | ||
| Q2 25 | 8.3% | 13.1% | ||
| Q1 25 | — | 13.2% | ||
| Q4 24 | 4.4% | 15.1% | ||
| Q3 24 | 2.8% | 13.9% | ||
| Q2 24 | 5.5% | 12.6% | ||
| Q1 24 | -21.9% | 11.6% |
| Q4 25 | 5.2% | 10.3% | ||
| Q3 25 | 4.1% | 8.7% | ||
| Q2 25 | 7.4% | 9.7% | ||
| Q1 25 | -74.0% | 11.8% | ||
| Q4 24 | 3.1% | 13.6% | ||
| Q3 24 | 1.8% | 9.7% | ||
| Q2 24 | 3.9% | 8.8% | ||
| Q1 24 | -19.8% | 8.0% |
| Q4 25 | $1.20 | $1.28 | ||
| Q3 25 | $0.91 | $0.98 | ||
| Q2 25 | $1.61 | $1.06 | ||
| Q1 25 | $-17.17 | $1.23 | ||
| Q4 24 | $1.08 | $1.58 | ||
| Q3 24 | $0.62 | $1.02 | ||
| Q2 24 | $1.38 | $0.93 | ||
| Q1 24 | $-7.78 | $0.81 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $594.8M | $4.5B |
| Total DebtLower is stronger | — | $10.0B |
| Stockholders' EquityBook value | $3.5B | $10.4B |
| Total Assets | $13.7B | $36.9B |
| Debt / EquityLower = less leverage | — | 0.96× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $594.8M | $4.5B | ||
| Q3 25 | $666.3M | $4.0B | ||
| Q2 25 | $1.0B | $3.7B | ||
| Q1 25 | $1.3B | $2.5B | ||
| Q4 24 | $697.6M | $2.9B | ||
| Q3 24 | $570.3M | $3.5B | ||
| Q2 24 | $618.5M | $2.0B | ||
| Q1 24 | $684.9M | $2.6B |
| Q4 25 | — | $10.0B | ||
| Q3 25 | — | $10.3B | ||
| Q2 25 | — | $10.3B | ||
| Q1 25 | $3.4B | $8.8B | ||
| Q4 24 | — | $9.0B | ||
| Q3 24 | — | $10.3B | ||
| Q2 24 | — | $9.2B | ||
| Q1 24 | $3.4B | $9.3B |
| Q4 25 | $3.5B | $10.4B | ||
| Q3 25 | $3.6B | $10.0B | ||
| Q2 25 | $3.9B | $9.7B | ||
| Q1 25 | $4.0B | $9.2B | ||
| Q4 24 | $7.6B | $8.4B | ||
| Q3 24 | $7.4B | $8.3B | ||
| Q2 24 | $7.3B | $7.8B | ||
| Q1 24 | $7.3B | $7.4B |
| Q4 25 | $13.7B | $36.9B | ||
| Q3 25 | $13.4B | $36.1B | ||
| Q2 25 | $18.3B | $35.5B | ||
| Q1 25 | $18.6B | $33.6B | ||
| Q4 24 | $23.3B | $33.1B | ||
| Q3 24 | $22.6B | $33.9B | ||
| Q2 24 | $22.1B | $31.9B | ||
| Q1 24 | $22.0B | $32.2B |
| Q4 25 | — | 0.96× | ||
| Q3 25 | — | 1.03× | ||
| Q2 25 | — | 1.06× | ||
| Q1 25 | 0.86× | 0.95× | ||
| Q4 24 | — | 1.06× | ||
| Q3 24 | — | 1.24× | ||
| Q2 24 | — | 1.18× | ||
| Q1 24 | 0.47× | 1.25× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $319.3M | — |
| Free Cash FlowOCF − Capex | $-57.1M | — |
| FCF MarginFCF / Revenue | -1.2% | — |
| Capex IntensityCapex / Revenue | 7.9% | 2.4% |
| Cash ConversionOCF / Net Profit | 1.31× | — |
| TTM Free Cash FlowTrailing 4 quarters | $394.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $319.3M | — | ||
| Q3 25 | $260.7M | — | ||
| Q2 25 | $378.5M | $94.0M | ||
| Q1 25 | $405.1M | $250.0M | ||
| Q4 24 | $785.6M | — | ||
| Q3 24 | $306.9M | — | ||
| Q2 24 | $695.7M | $-119.0M | ||
| Q1 24 | $1.3B | $419.0M |
| Q4 25 | $-57.1M | — | ||
| Q3 25 | $15.6M | — | ||
| Q2 25 | $129.7M | $8.0M | ||
| Q1 25 | $306.3M | $98.0M | ||
| Q4 24 | $359.2M | — | ||
| Q3 24 | $-193.8M | — | ||
| Q2 24 | $223.5M | $-183.0M | ||
| Q1 24 | $470.8M | $274.0M |
| Q4 25 | -1.2% | — | ||
| Q3 25 | 0.3% | — | ||
| Q2 25 | 2.8% | 0.2% | ||
| Q1 25 | 6.1% | 2.1% | ||
| Q4 24 | 4.8% | — | ||
| Q3 24 | -2.6% | — | ||
| Q2 24 | 2.9% | -3.8% | ||
| Q1 24 | 5.5% | 5.9% |
| Q4 25 | 7.9% | 2.4% | ||
| Q3 25 | 5.4% | 2.1% | ||
| Q2 25 | 5.4% | 1.7% | ||
| Q1 25 | 2.0% | 3.2% | ||
| Q4 24 | 5.6% | 1.9% | ||
| Q3 24 | 6.8% | 1.9% | ||
| Q2 24 | 6.2% | 1.3% | ||
| Q1 24 | 9.1% | 3.1% |
| Q4 25 | 1.31× | — | ||
| Q3 25 | 1.38× | — | ||
| Q2 25 | 1.10× | 0.19× | ||
| Q1 25 | — | 0.44× | ||
| Q4 24 | 3.37× | — | ||
| Q3 24 | 2.32× | — | ||
| Q2 24 | 2.32× | -0.28× | ||
| Q1 24 | — | 1.12× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DLTR
| Consumable | $2.4B | 50% |
| Variety | $2.1B | 43% |
| Seasonal | $344.1M | 7% |
GEHC
| Imaging Segment | $2.6B | 45% |
| PCS Segment | $824.0M | 14% |
| P Dx Segment | $790.0M | 14% |
| Specialized Ultrasound Subsegment | $735.0M | 13% |
| Monitoring Solutions Subsegment | $578.0M | 10% |
| Life Support Solutions Subsegment | $247.0M | 4% |
